Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TTRX · against 341 other Healthcare companies of similar size
Ranked #213 of 342 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score130 peers with a valuation score of 0–9, including TTRX · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | TTRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 327 reported | -2.9% | -0.4% | 42% | 30% | |
| EBITDA yieldHigher is better · 347 reported | -3.1% | 1.8% | 33% | 50% | |
| Free cash flow yieldHigher is better · 176 reported | -1.5% | -9.5% | 69% | 20% | |
| Book yieldHigher is better · 333 reported | 0.2% | 51.8% | 6% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 213 | 549M USD | 8 | 30 | |
| 213 | 371M USD | 8 | ||
| 213 | 394M USD | 8 | 37 | |
| 213 | 513M USD | 8 | 31 | |
| 213 | 289M USD | 8 | ||
| 213 | 522M USD | 8 | 12 | |
| 213 | 227M USD | 8 | 24 | |
| 213 | 453M USD | 8 | 6 | |
| 213 | 382M USD | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score